The work is an updated version of 'Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods' J Mol ModelDOI 10.1007/s00894-010-0745-1
If you can't find a free copy on the net, it's one of 3 articles I would recommend everyone gets. Then we are all on the same page and so far more productive. A good idea is a good idea whomever has the idea. I have NO ISSUE whoever has the idea and I know there are at least 3 other chemists who frequent this forum. I don't know how many medicinal chemists we have. Lipinski's rule of five with a Log upto 5 and a pKa so the so most of the compound is unprotonated in the blood. ADME is the most important acronym in med. chem. Of course, my education was 27 years ago.
CCC(=O)N([C@H]1CCN(C[C@@H](O)c2ccc(F)cc2)C[C@H]1C)c3ccccc3 - I strongly suspect that altering the fluorobenzene tp a 2-Thiophene would have more affinity
CN1CC[C@]23[C@@H]4C(=O)C=C[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)OC(=O)/C=C/C6=CC=CC=C6 - chosen for affinity & increase potency due to alkene
BrC1=CC=C(C=C1)[C@]2(N(C)C)CC[C@@](CC2)(O)CCC3=CC=CC=C3 - chosen because it breaks the morphine rule.
O=N(C1=CC=C(CCN2CCCC/C2=N\S(=O)(C3=CC=C(Cl)C=C3)=O)C=C1)=O - note use of sulfonamide. They tried it on fentanyl analogues - it didn't work
C[C@]12C(=O)CC[C@@]3([C@]14CCN([C@@H]3CC5=C4C(=C(C=C5)O)O2)C)OC - chosen for tertiary ether - like the Bentley compounds
Oc6ccc4c1c6O[C@H]3[C@]5(OC)[C@H](C[C@@]2([C@H](N(CC[C@@]123)C)C4)CC5)[C@@](O)(C)CCC - interesting that it's found the second aromatic AND because the duration is much longer than most high affinity compounds
CCC(N1[C@@H]2CC[C@H]1CN(C2)C/C=C/C3=CC=CC=C3)=O - alkene
CCOC1=CC=C(CC2=NC3=C(N2CCN(CC)CC)C=CC(N(=O)=O)=C3)C=C1 - high affinity, 2 aromatics. Could add the carboxamide for verisimilitude (in mammals it was 240 x M).
CN([C@H]1CCCC[C@@]11CCCN1C)C(=O)c1ccc(Br)c(Br)c1 - The logical conclusion of benzamides
O=C(CC)OC1(CCN(C)CC1CC=C)C2=CC=CC=C2 - for the allyl group which vastly increases potency.
C[C@]12C(=O)CC[C@@]3([C@]14CCN([C@@H]3CC5=C4C(=C(C=C5)O)O2)C)OCCCC6=CC=CC=C6 - strongest of the Schmidhammer modification.
CCC(=O)N([C@H](C)CN1CCC(c2ccccc2)C(C)(C)C1)c3ccccc3 - proof that phenapromide can be potent (x60 morphine)
COc1cc2CCN(C)C(CCS(=O)c3ccc(cc3)N(=O)=O)c2cc1OC - proof that metofoline isn't just an alternative to codeine.
CCC(=O)C(CCN1CCC2(CCCC3=CC=CC=C32)CC1)(C4=CC=CC=C4)C5=CC=CC=C5 - semi-rigid methadone derivative.
CC1Cc2cc(O)ccc2CCN1CCc3ccc(cc3)N(=O)=O - benzazepines CAN be potent.
CC1C2CCC[C@]1(CCC2Cc3ccccc3)c4cccc(O)c4 - rigid derivative of ketobemidone with a phenethyl group which may be substituted or the whole ring substitution to 2-thienyl.
O=C1CC(CN1)c2ccccc2.C(N3CCCCC3)c4ccccc4c5cccs5 - discovered when Paul Janssen was looking for neuroleptics. It has been noted that for many neuroleptics, replacing a =0 with a benzene = opioid
C=C1CC[C@@]6(O)[C@H]3Cc5ccc(O)c4O[C@@H]1[C@]6(CCN3CCc2ccccc2)c45 N-phenylethyl analogue of nalmefenev -well spotted of a phenanthacine with alkene. Thanks
CC[C@@H](C)N(C[C@H](O)[C@@H]1CCC(=O)N1Cc2ccccc2CC(F)(F)F)[C@H](F)CC - Viminol analogue x434 morphine
COc1cccc(c1)[C@@]23CCC[C@@H](N(CCc4ccccc4)CC2)C3=C benzomorphan with allyl & N-phenylethyl. Ki 0.19
And there are the 20. 20 totally different opioids and I wish to expand on the paper I mentioned from:
1-aromatic system
2-hydrogen-bond acceptors
1-positively ionizable function.
So only 4 sites have been found BUT it's clear a second aromatic is vital to high-potency. I will be running them through the software on the paper with the hops of adding -
2-aromatic systems
2-hydrogen-bond acceptors
1-alkene displaying van der waals forces
1-positively ionizable function.
So, please use a viewer to see the 20 totally unlike opioids in 2D but think in 3D and minimum-energy alignment. If you can think of more examples of scaffolds I haven't used, please speak up, the more the merrier. As I said, I intend to write a paper on the results so it WILL get read by hundreds if not 1000s. Anyone who finds another scaffold is, therefore, named in the paper. This is very useful if you haven't been published before. If you E-mail medicinal chemists, the first thing they do is look what papers you are on. Once you have 1, more people talk to you. Right now I'm involved in patenting a new class of benzodiazepines. As soon as the patent is given, I will run through how I got to them. Lesson 1 - Think like Paul Janssen!
Of course - I've discussed no synthesis - that would be Eunoia.